Global Valvular Heart Disease Treatment Market Size, Status and Forecast 2024-2031

Report ID: 933855 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cardiac Catheterization
        1.2.3 Electrocardiogram (ECG)
        1.2.4 Chest X-Ray
        1.2.5 Stress Test
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Valvular Heart Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital & Clinics
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Research Institutes
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Valvular Heart Disease Treatment Market Perspective (2016-2027)
    2.2 Valvular Heart Disease Treatment Growth Trends by Regions
        2.2.1 Valvular Heart Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Valvular Heart Disease Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Valvular Heart Disease Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Valvular Heart Disease Treatment Industry Dynamic
        2.3.1 Valvular Heart Disease Treatment Market Trends
        2.3.2 Valvular Heart Disease Treatment Market Drivers
        2.3.3 Valvular Heart Disease Treatment Market Challenges
        2.3.4 Valvular Heart Disease Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Valvular Heart Disease Treatment Players by Revenue
        3.1.1 Global Top Valvular Heart Disease Treatment Players by Revenue (2016-2021)
        3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Valvular Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Valvular Heart Disease Treatment Revenue
    3.4 Global Valvular Heart Disease Treatment Market Concentration Ratio
        3.4.1 Global Valvular Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Valvular Heart Disease Treatment Revenue in 2020
    3.5 Valvular Heart Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Valvular Heart Disease Treatment Product Solution and Service
    3.7 Date of Enter into Valvular Heart Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Valvular Heart Disease Treatment Breakdown Data by Type
    4.1 Global Valvular Heart Disease Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Valvular Heart Disease Treatment Breakdown Data by Application
    5.1 Global Valvular Heart Disease Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Valvular Heart Disease Treatment Market Size (2016-2027)
    6.2 North America Valvular Heart Disease Treatment Market Size by Type
        6.2.1 North America Valvular Heart Disease Treatment Market Size by Type (2016-2021)
        6.2.2 North America Valvular Heart Disease Treatment Market Size by Type (2022-2027)
        6.2.3 North America Valvular Heart Disease Treatment Market Size by Type (2016-2027)
    6.3 North America Valvular Heart Disease Treatment Market Size by Application
        6.3.1 North America Valvular Heart Disease Treatment Market Size by Application (2016-2021)
        6.3.2 North America Valvular Heart Disease Treatment Market Size by Application (2022-2027)
        6.3.3 North America Valvular Heart Disease Treatment Market Size by Application (2016-2027)
    6.4 North America Valvular Heart Disease Treatment Market Size by Country
        6.4.1 North America Valvular Heart Disease Treatment Market Size by Country (2016-2021)
        6.4.2 North America Valvular Heart Disease Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Valvular Heart Disease Treatment Market Size (2016-2027)
    7.2 Europe Valvular Heart Disease Treatment Market Size by Type
        7.2.1 Europe Valvular Heart Disease Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Valvular Heart Disease Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Valvular Heart Disease Treatment Market Size by Type (2016-2027)
    7.3 Europe Valvular Heart Disease Treatment Market Size by Application
        7.3.1 Europe Valvular Heart Disease Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Valvular Heart Disease Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Valvular Heart Disease Treatment Market Size by Application (2016-2027)
    7.4 Europe Valvular Heart Disease Treatment Market Size by Country
        7.4.1 Europe Valvular Heart Disease Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Valvular Heart Disease Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Valvular Heart Disease Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type
        8.2.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application
        8.3.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region
        8.4.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Valvular Heart Disease Treatment Market Size (2016-2027)
    9.2 Latin America Valvular Heart Disease Treatment Market Size by Type
        9.2.1 Latin America Valvular Heart Disease Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Valvular Heart Disease Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Valvular Heart Disease Treatment Market Size by Type (2016-2027)
    9.3 Latin America Valvular Heart Disease Treatment Market Size by Application
        9.3.1 Latin America Valvular Heart Disease Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Valvular Heart Disease Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Valvular Heart Disease Treatment Market Size by Application (2016-2027)
    9.4 Latin America Valvular Heart Disease Treatment Market Size by Country
        9.4.1 Latin America Valvular Heart Disease Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Valvular Heart Disease Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Valvular Heart Disease Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type
        10.2.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application
        10.3.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country
        10.4.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Valvular Heart Disease Treatment Introduction
        11.1.4 Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.1.5 Abbott Laboratories Recent Development
    11.2 B. Braun Melsungen AG
        11.2.1 B. Braun Melsungen AG Company Details
        11.2.2 B. Braun Melsungen AG Business Overview
        11.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Introduction
        11.2.4 B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.2.5 B. Braun Melsungen AG Recent Development
    11.3 Boston Scientific Corp.
        11.3.1 Boston Scientific Corp. Company Details
        11.3.2 Boston Scientific Corp. Business Overview
        11.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Introduction
        11.3.4 Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.3.5 Boston Scientific Corp. Recent Development
    11.4 Medtronic
        11.4.1 Medtronic Company Details
        11.4.2 Medtronic Business Overview
        11.4.3 Medtronic Valvular Heart Disease Treatment Introduction
        11.4.4 Medtronic Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.4.5 Medtronic Recent Development
    11.5 CryoLife Inc.
        11.5.1 CryoLife Inc. Company Details
        11.5.2 CryoLife Inc. Business Overview
        11.5.3 CryoLife Inc. Valvular Heart Disease Treatment Introduction
        11.5.4 CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.5.5 CryoLife Inc. Recent Development
    11.6 Edwards Lifesciences Corporation
        11.6.1 Edwards Lifesciences Corporation Company Details
        11.6.2 Edwards Lifesciences Corporation Business Overview
        11.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Introduction
        11.6.4 Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.6.5 Edwards Lifesciences Corporation Recent Development
    11.7 LivaNova PLC
        11.7.1 LivaNova PLC Company Details
        11.7.2 LivaNova PLC Business Overview
        11.7.3 LivaNova PLC Valvular Heart Disease Treatment Introduction
        11.7.4 LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.7.5 LivaNova PLC Recent Development
    11.8 Neovasc Inc.
        11.8.1 Neovasc Inc. Company Details
        11.8.2 Neovasc Inc. Business Overview
        11.8.3 Neovasc Inc. Valvular Heart Disease Treatment Introduction
        11.8.4 Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.8.5 Neovasc Inc. Recent Development
    11.9 Micro Interventional Devices
        11.9.1 Micro Interventional Devices Company Details
        11.9.2 Micro Interventional Devices Business Overview
        11.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Introduction
        11.9.4 Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.9.5 Micro Interventional Devices Recent Development
    11.10 Symetis SA
        11.10.1 Symetis SA Company Details
        11.10.2 Symetis SA Business Overview
        11.10.3 Symetis SA Valvular Heart Disease Treatment Introduction
        11.10.4 Symetis SA Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.10.5 Symetis SA Recent Development
    11.11 Jenavalve Technology
        11.11.1 Jenavalve Technology Company Details
        11.11.2 Jenavalve Technology Business Overview
        11.11.3 Jenavalve Technology Valvular Heart Disease Treatment Introduction
        11.11.4 Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.11.5 Jenavalve Technology Recent Development
    11.12 TTK Healthcare Limited
        11.12.1 TTK Healthcare Limited Company Details
        11.12.2 TTK Healthcare Limited Business Overview
        11.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Introduction
        11.12.4 TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.12.5 TTK Healthcare Limited Recent Development
    11.13 Colibri Heart Valve
        11.13.1 Colibri Heart Valve Company Details
        11.13.2 Colibri Heart Valve Business Overview
        11.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Introduction
        11.13.4 Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.13.5 Colibri Heart Valve Recent Development
    11.14 Lepu Medical Technology Co.
        11.14.1 Lepu Medical Technology Co. Company Details
        11.14.2 Lepu Medical Technology Co. Business Overview
        11.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Introduction
        11.14.4 Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.14.5 Lepu Medical Technology Co. Recent Development
    11.15 Braile Biomédica
        11.15.1 Braile Biomédica Company Details
        11.15.2 Braile Biomédica Business Overview
        11.15.3 Braile Biomédica Valvular Heart Disease Treatment Introduction
        11.15.4 Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2016-2021)
        11.15.5 Braile Biomédica Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Valvular Heart Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cardiac Catheterization
    Table 3. Key Players of Electrocardiogram (ECG)
    Table 4. Key Players of Chest X-Ray
    Table 5. Key Players of Stress Test
    Table 6. Key Players of Others
    Table 7. Global Valvular Heart Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Valvular Heart Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Valvular Heart Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Valvular Heart Disease Treatment Market Share by Regions (2016-2021)
    Table 11. Global Valvular Heart Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Valvular Heart Disease Treatment Market Share by Regions (2022-2027)
    Table 13. Valvular Heart Disease Treatment Market Trends
    Table 14. Valvular Heart Disease Treatment Market Drivers
    Table 15. Valvular Heart Disease Treatment Market Challenges
    Table 16. Valvular Heart Disease Treatment Market Restraints
    Table 17. Global Valvular Heart Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Valvular Heart Disease Treatment Market Share by Players (2016-2021)
    Table 19. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valvular Heart Disease Treatment as of 2020)
    Table 20. Ranking of Global Top Valvular Heart Disease Treatment Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Valvular Heart Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Valvular Heart Disease Treatment Product Solution and Service
    Table 24. Date of Enter into Valvular Heart Disease Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2016-2021)
    Table 28. Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Valvular Heart Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Valvular Heart Disease Treatment Revenue Market Share by Application (2016-2021)
    Table 32. Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Valvular Heart Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Abbott Laboratories Company Details
    Table 65. Abbott Laboratories Business Overview
    Table 66. Abbott Laboratories Valvular Heart Disease Treatment Product
    Table 67. Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 68. Abbott Laboratories Recent Development
    Table 69. B. Braun Melsungen AG Company Details
    Table 70. B. Braun Melsungen AG Business Overview
    Table 71. B. Braun Melsungen AG Valvular Heart Disease Treatment Product
    Table 72. B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 73. B. Braun Melsungen AG Recent Development
    Table 74. Boston Scientific Corp. Company Details
    Table 75. Boston Scientific Corp. Business Overview
    Table 76. Boston Scientific Corp. Valvular Heart Disease Treatment Product
    Table 77. Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 78. Boston Scientific Corp. Recent Development
    Table 79. Medtronic Company Details
    Table 80. Medtronic Business Overview
    Table 81. Medtronic Valvular Heart Disease Treatment Product
    Table 82. Medtronic Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 83. Medtronic Recent Development
    Table 84. CryoLife Inc. Company Details
    Table 85. CryoLife Inc. Business Overview
    Table 86. CryoLife Inc. Valvular Heart Disease Treatment Product
    Table 87. CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 88. CryoLife Inc. Recent Development
    Table 89. Edwards Lifesciences Corporation Company Details
    Table 90. Edwards Lifesciences Corporation Business Overview
    Table 91. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product
    Table 92. Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 93. Edwards Lifesciences Corporation Recent Development
    Table 94. LivaNova PLC Company Details
    Table 95. LivaNova PLC Business Overview
    Table 96. LivaNova PLC Valvular Heart Disease Treatment Product
    Table 97. LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 98. LivaNova PLC Recent Development
    Table 99. Neovasc Inc. Company Details
    Table 100. Neovasc Inc. Business Overview
    Table 101. Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 102. Neovasc Inc. Recent Development
    Table 103. Micro Interventional Devices Company Details
    Table 104. Micro Interventional Devices Business Overview
    Table 105. Micro Interventional Devices Valvular Heart Disease Treatment Product
    Table 106. Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 107. Micro Interventional Devices Recent Development
    Table 108. Symetis SA Company Details
    Table 109. Symetis SA Business Overview
    Table 110. Symetis SA Valvular Heart Disease Treatment Product
    Table 111. Symetis SA Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 112. Symetis SA Recent Development
    Table 113. Jenavalve Technology Company Details
    Table 114. Jenavalve Technology Business Overview
    Table 115. Jenavalve Technology Valvular Heart Disease Treatment Product
    Table 116. Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 117. Jenavalve Technology Recent Development
    Table 118. TTK Healthcare Limited Company Details
    Table 119. TTK Healthcare Limited Business Overview
    Table 120. TTK Healthcare Limited Valvular Heart Disease Treatment Product
    Table 121. TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 122. TTK Healthcare Limited Recent Development
    Table 123. Colibri Heart Valve Company Details
    Table 124. Colibri Heart Valve Business Overview
    Table 125. Colibri Heart Valve Valvular Heart Disease Treatment Product
    Table 126. Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 127. Colibri Heart Valve Recent Development
    Table 128. Lepu Medical Technology Co. Company Details
    Table 129. Lepu Medical Technology Co. Business Overview
    Table 130. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product
    Table 131. Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 132. Lepu Medical Technology Co. Recent Development
    Table 133. Braile Biomédica Company Details
    Table 134. Braile Biomédica Business Overview
    Table 135. Braile Biomédica Valvular Heart Disease Treatment Product
    Table 136. Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
    Table 137. Braile Biomédica Recent Development
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Valvular Heart Disease Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Cardiac Catheterization Features
    Figure 3. Electrocardiogram (ECG) Features
    Figure 4. Chest X-Ray Features
    Figure 5. Stress Test Features
    Figure 6. Others Features
    Figure 7. Global Valvular Heart Disease Treatment Market Share by Application: 2020 VS 2027
    Figure 8. Hospital & Clinics Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Research Institutes Case Studies
    Figure 11. Valvular Heart Disease Treatment Report Years Considered
    Figure 12. Global Valvular Heart Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Valvular Heart Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Valvular Heart Disease Treatment Market Share by Regions: 2020 VS 2027
    Figure 15. Global Valvular Heart Disease Treatment Market Share by Regions (2022-2027)
    Figure 16. Global Valvular Heart Disease Treatment Market Share by Players in 2020
    Figure 17. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valvular Heart Disease Treatment as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Valvular Heart Disease Treatment Revenue in 2020
    Figure 19. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2016-2021)
    Figure 20. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2022-2027)
    Figure 21. North America Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Valvular Heart Disease Treatment Market Share by Type (2016-2027)
    Figure 23. North America Valvular Heart Disease Treatment Market Share by Application (2016-2027)
    Figure 24. North America Valvular Heart Disease Treatment Market Share by Country (2016-2027)
    Figure 25. United States Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Valvular Heart Disease Treatment Market Share by Type (2016-2027)
    Figure 29. Europe Valvular Heart Disease Treatment Market Share by Application (2016-2027)
    Figure 30. Europe Valvular Heart Disease Treatment Market Share by Country (2016-2027)
    Figure 31. Germany Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Valvular Heart Disease Treatment Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Valvular Heart Disease Treatment Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Valvular Heart Disease Treatment Market Share by Region (2016-2027)
    Figure 41. China Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Valvular Heart Disease Treatment Market Share by Type (2016-2027)
    Figure 49. Latin America Valvular Heart Disease Treatment Market Share by Application (2016-2027)
    Figure 50. Latin America Valvular Heart Disease Treatment Market Share by Country (2016-2027)
    Figure 51. Mexico Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Valvular Heart Disease Treatment Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Valvular Heart Disease Treatment Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Valvular Heart Disease Treatment Market Share by Country (2016-2027)
    Figure 57. Turkey Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 61. B. Braun Melsungen AG Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 62. Boston Scientific Corp. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 63. Medtronic Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 64. CryoLife Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 65. Edwards Lifesciences Corporation Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 66. LivaNova PLC Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 67. Neovasc Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 68. Micro Interventional Devices Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 69. Symetis SA Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 70. Jenavalve Technology Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 71. TTK Healthcare Limited Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 72. Colibri Heart Valve Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 73. Lepu Medical Technology Co. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 74. Braile Biomédica Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
B. Braun Melsungen AG
Boston Scientific Corp.
Medtronic
CryoLife Inc.
Edwards Lifesciences Corporation
LivaNova PLC
Neovasc Inc.
Micro Interventional Devices
Symetis SA
Jenavalve Technology
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology Co.
Braile Biomédica
Frequently Asked Questions
Valvular Heart Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Valvular Heart Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Valvular Heart Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Brazing Consumable

Brazing is a process of metal joining in which fusing of metal is done by the process of melting  ... Read More

Smart Indoor Garden

The smart indoor garden system is an advanced technology that enables users to grow fresh plants, ... Read More